Elimination of acquired resistance to PD-1 blockade via the concurrent depletion of tumour cells and immunosuppressive cells

Antigen release resulting from the death of tumour cells induced by chemotherapies and targeted therapies can augment the antitumor responses induced by immune checkpoint blockade (ICB). However, tumours responding to ICB therapies often become resistant to them. Here, we show that the specific targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Gang, Wang, Ziyu, Zheng, Ningbo, Fang, Jing, Mao, Chengqiong, Li, Xiaoyin, Jin, Guangxu, Ming, Xin, Lu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595849/
https://www.ncbi.nlm.nih.gov/pubmed/34725506
http://dx.doi.org/10.1038/s41551-021-00799-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595849/
https://www.ncbi.nlm.nih.gov/pubmed/34725506
http://dx.doi.org/10.1038/s41551-021-00799-6

Ejemplares similares